2024-05-10  5:31:10 PM Chg. +0.40 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
116.40CHF +0.34% 7,825
Turnover: 910,253.70
115.00Bid Size: 400 120.00Ask Size: 50 2.33 bill.CHF - -

Business description

Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine.Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta’s innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient.Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 40 countries.
 

Management board & Supervisory board

CEO
Francesco Siccardi
Management board
Corrado Farsetta, Alessandro Siccardi
Supervisory board
Alberto Siccardi, Maria Luisa Siccardi Tonolli, VIctor Balli, Ricardo Braglia, Philippe Weber
 

Company data

Name: Medacta Group N
Address: Gewerbestrasse 3,8500 Frauenfeld
Phone: +41-0-848-423-423
Fax: +41-0-848-423-424
E-mail: kontakt@medacta.ch
Internet: https://www.medacta.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12-31
Free Float: 30.40%
IPO date: 2019-04-04

Investor relations

Name: -
IR phone: +41-91-696-60-60
IR Fax: +41-91-696-60-66
IR e-mail: investor.relations@medacta.ch

Company calendar

CW 20 | 2024-05-13 Record Date
CW 20 | 2024-05-14 Dividend Payment
CW 39 | 2024-09-25 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Siccardi family
 
69.45%
Others
 
27.32%
Artisan Partners Limited Partnership
 
3.23%